Skip to content
facebook
twitter
linkedin
youtube
Toggle navigation
L36, 1 Macquarie Place, Sydney, NSW 2000
+61 2 8051 3043
info@raceoncology.com
Home
About
Science
Management team
Investors
News
CONTACT US
×
Contact Us
Δ
Race Oncology Investor Briefing – Melbourne 20th Oct 2022
Browse
Home
Featured
Race Oncology Investor Briefing – Melbourne 20th Oct 2022
02
Nov
Nov
, 02 ,
2022
Daniel Tillett
Facebook
Tweet
LinkedIn
Related posts:
September 2022 Quarterly Activity Report & Appendix 4C
Pitt Street Research Initiates Coverage of Race Oncology
Zantrene Protects Mouse Hearts from Chemotherapy Damage
Post navigation
Previous
Previous post:
Next
Next post:
Race Oncology
Targeting Zantrene® towards better cancer outcomes
Contact Us
©2022 Race Oncology Ltd
